IIM
RCUS icon

INTECH Investment Management’s Arcus Biosciences RCUS Stock Holding History

INTECH Investment Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$887K Buy
41,066
+16,249
+65% +$351K 0.01% 1067
2025
Q4 		$591K Buy
24,817
+4,985
+25% +$102K 0.01% 1418
2025
Q3 		$270K Sell
19,832
-14,570
-42% -$151K ﹤0.01% 1892
2025
Q2 		$280K Sell
34,402
-4,908
-12% -$41.9K ﹤0.01% 1904
2025
Q1 		$309K Buy
39,310
+13,155
+50% +$153K ﹤0.01% 1870
2024
Q4 		$389K Buy
26,155
+10,196
+64% +$167K ﹤0.01% 1699
2024
Q3 		$244K Buy
+15,959
New +$252K ﹤0.01% 1630

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

INTECH Investment Management's RCUS Position: Q1 2026 in Review

INTECH Investment Management increased its Arcus Biosciences (RCUS) stake by 65% in Q1 2026, buying an estimated $351K and bringing the position to 41,066 shares worth $887K. The position accounts for 0.01% of the portfolio, ranked #1067.

INTECH Investment Management first reported a position in RCUS in Q3 2024 and has held it in 7 quarters since. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • INTECH Investment Management held 41,066 shares of Arcus Biosciences worth $887K as of Q1 2026.
  • INTECH Investment Management bought 16,249 Arcus Biosciences shares in Q1 2026, an estimated $351K.
  • Arcus Biosciences made up 0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1067 holding.
  • INTECH Investment Management first reported a position in Arcus Biosciences in Q3 2024 and has held it in 7 quarters since.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.